KIORA PHARMACEUTICALS INC (KPRX) Stock Earnings & Estimates
USA - NASDAQ:KPRX - US49721T5074 - Common Stock
2.61 USD
+0.04 (+1.48%)
2.6099 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 16.02M | 1.53M -90.45% | 765K -50.00% | -100.00% | 23.231M | 68.735M 195.88% | 171.13M 148.97% | 243.19M 42.11% | 306.5M 26.03% | |||
| EBITDA YoY % growth | -12.27M -20.89% | -10.631M 13.36% | 6.538M 161.50% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -12.31M -20.69% | -10.683M 13.22% | 6.518M 161.02% | -10.517M -261.34% | -15.318M -45.65% | -27.336M -78.46% | -7.666M 71.96% | 31.825M 515.13% | 117.86M 270.34% | 181.25M 53.78% | 242.03M 33.53% | |
| Operating Margin | N/A | N/A | 40.69% | -687.37% | -2,002.33% | N/A | -33.00% | 46.30% | 68.87% | 74.53% | 78.97% | |
| EPS YoY % growth | -232.11 61.43% | -28.35 87.79% | 1.04 103.67% | -2.58 -347.64% | -2.40 6.93% | -2.10 12.34% | -0.19 90.78% | 5.65 3,015.79% | 16.49 191.88% | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.75 7.44% | -0.77 26.44% | -0.59 -13.77% | -0.69 -27.50% | -0.59 21.09% | -0.60 21.33% |
| Revenue Q2Q % growth | 765K | 765K | 765K | -100.00% | -100.00% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.8M -75.63% | -2.896M -12.91% | -3.428M -47.11% | -5.173M -115.90% | -5.605M -100.18% | -5.82M -100.99% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.54 -1.89% | -0.62 | 0.08 | 12.49% |
| Q1 2025 Q2Q % growth | -0.52 -115.20% | -0.68 | 0.16 | 23.91% |
| Q4 2024 Q2Q % growth | -1.04 75.41% | -0.56 | -0.48 | -85.38% |
| Q3 2024 Q2Q % growth | -0.81 89.89% | -0.78 | -0.03 | -3.94% |
| Q2 2024 Q2Q % growth | -0.53 92.55% | -0.87 | 0.34 | 39.35% |
| Q1 2024 Q2Q % growth | 3.42 138.00% | -0.61 | 4.03 | 664.47% |
| Q4 2023 Q2Q % growth | -4.23 73.25% | -3.84 | -0.39 | -10.10% |
| Q3 2023 Q2Q % growth | -8.01 85.25% | -3.24 | -4.77 | -146.95% |
| Q2 2023 Q2Q % growth | -7.11 89.03% | -9.78 | 2.67 | 27.31% |
| Q1 2023 Q2Q % growth | -9.00 90.74% | -15.47 | 6.47 | 41.82% |
| Q4 2022 Q2Q % growth | -15.81 93.36% | -22.58 | 6.77 | 29.97% |
| Q3 2022 Q2Q % growth | -54.30 47.99% | -35.21 | -19.09 | -54.23% |
| Q2 2022 Q2Q % growth | -64.80 48.57% | -73.44 | 8.64 | 11.76% |
| Q1 2022 Q2Q % growth | -97.20 27.03% | -86.29 | -10.91 | -12.64% |
| Q4 2021 Q2Q % growth | -238.26 -27.27% | -84.46 | -153.80 | -182.11% |
| Q3 2021 Q2Q % growth | -104.40 34.09% | -123.63 | 19.23 | 15.55% |
| Q2 2021 Q2Q % growth | -126.00 7.89% | -153.00 | 27.00 | 17.65% |
| Q1 2021 Q2Q % growth | -133.20 | -141.37 | 8.17 | 5.78% |
| Q4 2020 Q2Q % growth | -187.20 27.27% | -161.57 | -25.63 | -15.86% |
| Q3 2020 Q2Q % growth | -158.40 | -154.22 | -4.18 | -2.71% |
| Q2 2020 Q2Q % growth | -136.80 36.67% | -157.90 | 21.10 | 13.36% |
| Q4 2019 Q2Q % growth | -257.40 | -297.43 | 40.03 | 13.46% |
| Q2 2019 Q2Q % growth | -216.00 | -275.40 | 59.40 | 21.57% |
| Q1 2019 Q2Q % growth | 54.00 | -275.40 | 329.40 | 119.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q1 2025 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q4 2024 Q2Q % growth | 765K | -765K | -100.00% | |
| Q3 2024 Q2Q % growth | 7.14K | -7.14K | -100.00% | |
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2020 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -11.36% | -22.5% | -4.55% | 0% |
| Revenue | 0% | 0% | 0% | -33.33% |